CNS & Neurological Disorders - Drug Targets

(Formerly Current Drug Targets - CNS & Neurological Disorders)

Editor-in-Chief:

Stephen D. Skaper  
Department of Pharmaceutical and Pharmacological Sciences
University of Padova
Padova
Italy

Back

Ahead of Print Article(s)

K+ Channels of Müller Glial Cells in Retinal Disorders

Volume:17
Feng Gao, Linjie Xu, Yuan Zhao, Xinghuai Sun and Zhongfeng Wang*

In silico Ligand-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease

Volume:17
Mohammad Usman Mirza*, Nazia Ikram, Nauman Mazhar, Kanzal Iman, Mehwish Riaz and Mohammad A Kamal

Mambalgins, the Venom-origin Peptides as a Potentially Novel Group of Analgesics: Mini Review

Volume:17
Maksymilian Aleksander Brzezicki* and Przemyslaw Temistokles Zakowicz

Systemic Administration of Antipsychotic Asenapine Pre or Postnatal does not Induce Anxiety-like Behaviors in Mice

Volume:17
Maria Silvia Oliveira*, Thais Souza Barbosa de Souza, Daniela Miranda Farias, Rozimeri Fatima Coletti, Jorge Aparecido de Barros, Carolina Gomes Carrilho, Susana Elisa Moreno, Eric Murillo Murillo Rodriguez, Sergio Machado and Andre Barciela Veras

Cognitive Impact of Cerebellar Damage: Is There a Future for Cognitive Rehabilitation?

Volume:17
Kim van Dun, Frank Van Overwalle, Mario Manto* and Peter Marien

Role of Epigenetics and Oxidative Stress in Gliomagenesis

Volume:17
Edgar Rangel-Lopez*, Yesennia Sanchez-Perez, Ernesto Soto-Reyes, Claudia Maria Garcia-Cuellar, Bernardo Cacho-Diaz and Abel Santamaria

Literature Evidence and ARRIVE Assessment on Neuroprotective Effects of Flavonols in Neurodegenerative Diseases’ Models

Volume:17
Ana Carolina Bombardi Duarte, Maycon Giovanni Santana, Guilherme di Camilo Orfali, Carlos Tadeu Parisi and Denise Goncalves Priolli*

Development of a Nasal Donepezil-loaded Microemulsion for the Treatment of Alzheimer’s Disease: in vitro and ex vivo Characterization

Volume:17
Lupe Carolina Espinoza, Marisol Vacacela, Beatriz Clares*, Maria Luisa Garcia, Maria Jose Fabrega and Ana Cristina Calpena

The Combined Effects of ω-3 Fatty Acids and Nano-Curcumin Supplementation on Intercellular Adhesion Molecule-1 (ICAM-1) Gene Expression and Serum Levels in Migraine Patients

Volume:17
Neda Soveyd, Mina Abdolahi, Mahmoud Djalali, Mahsa Hatami, Abbas Tafakhori, Payam Sarraf and Niyaz Mohammadzadeh Honarvar*

Low Dose of Anisodine Hydrobromide Induced Neuroprotective Effects in Chronic Cerebral Hypoperfusion Rats

Volume:16
Dandan Chen*, Xiaofang Xie, Qiuling Chen, Han Liu, Shiyang Zhang, Feng Wan, Hui Ao and Cheng Peng

Targeted Blockade of TARP-γ8-Associated AMPA Receptors: Anticonvulsant Activity with the Selective Antagonist LY3130481 (CERC-611)

Volume:16
Jeffrey M. Witkin*, Douglas A. Schober, Scott D. Gleason, John T. Catlow, Warren J. Porter, Jon Reel, X. Jin, J. Hobbs, Donald Gehlert, Douglas L. Gernert, Kevin M Gardinier, Akihiko S Kato, X. Ping and J. L. Smith

Commentary: Endophenotypes as Disease Modifiers: Decoding the Biology of Alzheimer’s by Genome-wide Association Studies

Volume:16
A. R. Neelakandan and G. K. Rajanikant*

Neurotransplantation Therapy and Cerebellar Reserve

Volume:16
Jan Cendelin, Hiroshi Mitoma* and Mario Manto

Antidepressant Potential of Peptides: New Insights as Future Therapeutic

Volume:16
Haroon Khan*, Sumaira Khattak, Mohammad S. Mubarak, Saud S. Bawazeer, Tareq Abu-Izneid and Mohammad A. Kamal

NF-κB as a Key Mediator of Brain Inflammation in Alzheimer’s Disease

Volume:16
Chul Ju Hwang, Dong-Young Choi, Mi Hee Park and Jin Tae Hong*

Toward a Personalized Medicine in Wake-Up Stroke?

Volume:16
Burak Yulug*, Lütfü Hanoglu and Ertugrul Kilic

C-Abl Inhibition; A Novel Therapeutic Target for Parkinson’s Disease

Volume:16
Abdelrahman Ibrahim Abushouk, Ahmed Negida*, Rasha Abdelsalam Elshenawy, Hossam Zein, Ali M Hammad, Ahmed Menshawy and Wael M.Y. Mohamed

Recalling Memory by Brain Stimulation

Volume:16
Arias-Carrion*

Let the Time Fly: Dopamine is the Arbiter

Volume:16
Xiaodong Liu, Changzheng Zhang, Oscar Arias-Carrion* and Ti-Fei Yuan*